Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Newitt

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Translational Oncology|April 29, 2014
Repeatability of quantitative MRI measurements in normal breast tissueSheye O Aliu, Ella F Jones, Ania Azziz, et al.
Tomography (Ann Arbor, Mich.)|June 1, 2022
Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast CancerNu N Le, Wen Li, Natsuko Onishi, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Retrospective Correction of ADC for Gradient Nonlinearity Errors in Multicenter Breast DWI Trials: ACRIN6698 Multiplatform Feasibility StudyDariya I Malyarenko, David C Newitt, Ghoncheh Amouzandeh, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast CancerWen Li, David C Newitt, Bo La Yun, et al.
Academic Radiology|April 11, 2013
High-resolution diffusion-weighted imaging for monitoring breast cancer treatment responseLisa J Wilmes, Rebekah L McLaughlin, David C Newitt, et al.
Journal of Medical Imaging (Bellingham, Wash.)|November 15, 2017
Toward uniform implementation of parametric map Digital Imaging and Communication in Medicine standard in multisite quantitative diffusion imaging studiesDariya Malyarenko, Andriy Fedorov, Laura Bell, et al.
Radiology|December 2, 2015
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIALNola M Hylton, Constantine A Gatsonis, Mark A Rosen, et al.
NPJ Breast Cancer|March 26, 2021
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence riskMark Jesus M Magbanua, Wen Li, Denise M Wolf, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 24, 2018
Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trialDavid C Newitt, Zheng Zhang, Jessica E Gibbs, et al.
Radiology|September 5, 2018
Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter TrialSavannah C Partridge, Zheng Zhang, David C Newitt, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Translational Oncology|April 29, 2014
Repeatability of quantitative MRI measurements in normal breast tissueSheye O Aliu, Ella F Jones, Ania Azziz, et al.
Tomography (Ann Arbor, Mich.)|June 1, 2022
Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast CancerNu N Le, Wen Li, Natsuko Onishi, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Retrospective Correction of ADC for Gradient Nonlinearity Errors in Multicenter Breast DWI Trials: ACRIN6698 Multiplatform Feasibility StudyDariya I Malyarenko, David C Newitt, Ghoncheh Amouzandeh, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast CancerWen Li, David C Newitt, Bo La Yun, et al.
Academic Radiology|April 11, 2013
High-resolution diffusion-weighted imaging for monitoring breast cancer treatment responseLisa J Wilmes, Rebekah L McLaughlin, David C Newitt, et al.
Journal of Medical Imaging (Bellingham, Wash.)|November 15, 2017
Toward uniform implementation of parametric map Digital Imaging and Communication in Medicine standard in multisite quantitative diffusion imaging studiesDariya Malyarenko, Andriy Fedorov, Laura Bell, et al.
Radiology|December 2, 2015
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIALNola M Hylton, Constantine A Gatsonis, Mark A Rosen, et al.
NPJ Breast Cancer|March 26, 2021
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence riskMark Jesus M Magbanua, Wen Li, Denise M Wolf, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 24, 2018
Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trialDavid C Newitt, Zheng Zhang, Jessica E Gibbs, et al.
Radiology|September 5, 2018
Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter TrialSavannah C Partridge, Zheng Zhang, David C Newitt, et al.
Pageof 5